When can cytomegalovirus prophylaxis and maintenance therapy be stopped in HIV disease?

被引：8
作者：
Deayton, JR [1 ]
Griffiths, PD [1 ]
机构：
[1] UCL Royal Free & Univ Coll Med Sch, Dept Virol, London NW3 2PF, England
来源：
CURRENT OPINION IN INFECTIOUS DISEASES | 2000年 / 13卷 / 06期
关键词：
D O I：
10.1097/00001432-200012000-00010
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Highly active antiretroviral therapy (HAART) can restore immune responses to a variety of pathogens, including cytomegalovirus. Following successful HAART, prophylaxis and maintenance therapy for cytomegalovirus can safely be stopped in selected patients. However, the risk of cytomegalovirus disease progression recurs if HAART fails, and so these patients require careful monitoring. Curr Opin Infect Dis 13:637-641. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码：637 / 641
页数：5
相关论文
共 46 条
  • [1] Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease
    Autran, B
    Carcelain, G
    Li, TS
    Blanc, C
    Mathez, D
    Tubiana, R
    Katlama, C
    Debre, P
    Leibowitch, J
    [J]. SCIENCE, 1997, 277 (5322) : 112 - 116
  • [2] Cytomegalovirus polymerase chain reaction viraemia in patients receiving ganciclovir maintenance therapy for retinitis
    Bowen, EF
    Emery, VC
    Wilson, P
    Johnson, MA
    Davey, CC
    Sabin, CA
    Farmer, D
    Griffiths, PD
    [J]. AIDS, 1998, 12 (06) : 605 - 611
  • [3] Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease
    Bowen, EF
    Sabin, CA
    Wilson, P
    Griffiths, PD
    Davey, CC
    Johnson, MA
    Emery, VC
    [J]. AIDS, 1997, 11 (07) : 889 - 893
  • [4] Bowen EF, 1996, AIDS, V10, P1515, DOI 10.1097/00002030-199611000-00009
  • [5] Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy
    Casado, JL
    Arrizabalaga, J
    Montes, M
    Martí-Belda, P
    Tural, C
    Pinilla, J
    Gutierrez, C
    Portu, J
    Schuurman, R
    Aguirrebengoa, K
    [J]. AIDS, 1999, 13 (12) : 1497 - 1502
  • [6] Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy
    Cassoux, N
    Lumbroso, L
    Bodaghi, B
    Zazoun, L
    Katlama, C
    LeHoang, P
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1999, 83 (01) : 47 - 49
  • [7] Usefulness of the cytomegalovirus (CMV) antigenemia assay for predicting the occurrence of CMV disease and death in patients with AIDS
    Chevret, S
    Scieux, C
    Garrait, V
    Dahel, L
    Morinet, F
    Modaï, J
    Decazes, JM
    Molina, JM
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 28 (04) : 758 - 763
  • [8] Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy
    Deayton, J
    Mocroft, A
    Wilson, P
    Emery, VC
    Johnson, MA
    Griffiths, PD
    [J]. AIDS, 1999, 13 (10) : 1203 - 1206
  • [9] Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy
    Deayton, JR
    Wilson, P
    Sabin, CA
    Davey, CC
    Johnson, MA
    Emery, VC
    Griffiths, PD
    [J]. AIDS, 2000, 14 (09) : 1163 - 1170
  • [10] Recovery of long-term natural protection against reactivation of CMV retinitis in AIDS patients responding to highly active antiretroviral therapy
    Di Perri, G
    Vento, S
    Mazzi, R
    Bonora, S
    Bonora, A
    Trevenzoli, M
    Allegranzi, B
    Carretta, G
    Lanzafame, M
    Pizzighella, S
    Concia, E
    [J]. JOURNAL OF INFECTION, 1999, 39 (03) : 193 - 197
12345